Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-108057·Anika Therapeutics, Inc.
Schedule 13G ownership disclosure
ANIKA THERAPEUTICS INC
Common Stock, Par Value $0.01 Per Share · CUSIP: 035255108
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Trigran Investments, Inc.
Shares: 1,621,215.00 · Class: 11.2%
- Douglas T. Granat
Shares: 1,621,215.00 · Class: 11.2%
- Lawrence A. Oberman
Shares: 1,621,215.00 · Class: 11.2%
- Steven G. Simon
Shares: 1,621,215.00 · Class: 11.2%
- Bradley F. Simon
Shares: 1,621,215.00 · Class: 11.2%
- Steven R. Monieson
Shares: 1,621,215.00 · Class: 11.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-108057
- Form type
- SCHEDULE 13G/A
- Filer
- Anika Therapeutics, Inc.
- CIK
- CIK 898437
- Filed
- Nov 07, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership